The Pandemic and All-Hazards Preparedness Act offers a unique opportunity for the US government to leverage the talents of industry, academia and public health to better prepare for natural, man-made or accidental threats to the American people. The reauthorization of this important legislation represents an opportunity to strengthen the medical countermeasure enterprise by continuing to improve the partnership between industry and the US government.

Key leaders from the Administration and Congress, along with leaders from industry, will share the key principles and initiatives included in the legislation and discuss how these provisions will benefit companies developing medical countermeasures as well as enabling our national resilience.

Ability Level: Intermediate

Session ID: 21267